Novartis International AG

British Chamber of Commerce
Business Europe Trial membership
Cancer Patient Europe
Critical Medicines Alliance
ECPA
EFPIA - Pillar 3 IMI
EFPIA (Pillar 1+2)
EFPIA Campaign mode
EFPIA Country engagement
EFPIA CVD Workstream
EFPIA: Pillar 3 ICH
EPF 20th Anniversary Policy Event
EPF Annual Plan
EPF HTA Simulation Project
Eucope (Membership)
EUCOPE ECGP Coalition
Eucope Membership - Support to the incentive Steering Group
EUCOPE TRANSFORM
EUMatrix
EuropaBio
European Access Academy
European Alliance for Access to Safe Medicines (EAASM)
European Alliance for Personalised Medicine Sponsorship
European Brain Council
European Business Summit
European Cancer Organisation (ECO)
European Kidney Health Alliance (EKHA)
EuropeanIssuers
EURORDIS
FH Europe Foundation
Friends of Europe
International Agency for the Prevention of Blindness (IAPB)
International Patient Organisation for Primary Immunodeficiencies (IPOPI)
Kangaroo
Medicines for Europe
Medicines for Europe Biosimilar Medicines
Medicines for Europe VAM
MedTech Europe
Nuclear Medicine Europe (NMEU)
Science Business Membership
SMA Alliance on NBS
SPARC

None declared

Promotes their own interests or the collective interests of their members

Jan 2023 - Dec 2023

2,000,000€ - 2,249,999€

None declared

2,000,000€ - 2,249,999€

We have calculated the estimate of annual costs related to activities covered by the register by adding our membership fees, event costs, consultancy fees together with facilities (rental charges) and personal costs.

None declared

N/A

European Parliament lunch meeting on health data and rare diseases
European Parliament exhibition on heart health
European Parliament German speaking round table on IP
French speaking stakeholder event on the GPL
European Health Summit - session on GPL
Expert briefing sessions on Cell and Gene Therapies and rare diseases
Publication of Neuroendocrine Tumour Policy Recommendations
Communication efforts around radiopharmaceuticals in EU pharmaceutical legislation

None declared

28 meetings found. Download meetings

The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.

• Date	06 Mar 2023	Location	Brussels
  Subject	Pharma package
  Cabinet	Cabinet of Executive Vice-President Valdis Dombrovskis
  Portfolio	An Economy that Works for People
  Attending	Kevin Keary (Cabinet member)
  Other Lobbyists	EuropaBio

• Date	13 Feb 2023	Location	Brussels
  Subject	EU strategic autonomy in the health sector
  Cabinet	Cabinet of Vice-President Margaritis Schinas
  Portfolio	Promoting the European Way of Life
  Attending	Maria Luisa Llano Cardenal (Cabinet member)

• Date	10 Jan 2023	Location	Brussels
  Subject	Commission Proposal for Directive on sustainability - Due Diligence (CSDDD)
  Cabinet	Cabinet of Commissioner Didier Reynders
  Portfolio	Justice
  Attending	Ludovic Pierre (Cabinet member) Lucrezia Busa (Cabinet member)

• Date	06 Oct 2022	Location	Videoconference
  Subject	Energy prices’ impact on generic medicines manufacturing
  Cabinet	Cabinet of Commissioner Thierry Breton
  Portfolio	Internal Market
  Attending	Eszter Batta (Cabinet member) Maurits-Jan Prinz (Cabinet member)

• Date	18 Feb 2021	Location	Videoconference
  Subject	COVID-19 vaccines production
  Cabinet	Cabinet of Commissioner Thierry Breton
  Portfolio	Internal Market
  Attending	Eszter Batta (Cabinet member) Thierry Breton (Commissioner)

• Date	03 Sep 2020	Location	Videoconference
  Subject	Keeping existing pharmaceutical manufacturing capacity in the EU
  Cabinet	Cabinet of Commissioner Thierry Breton
  Portfolio	Internal Market
  Attending	Eszter Batta (Cabinet member)

• Date	07 Apr 2020	Location	Brussels
  Subject	Discussion on medicines (Production, clinical tests, supply and allocation)
  Cabinet	Cabinet of Commissioner Stella Kyriakides
  Portfolio	Health
  Attending	Stella Kyriakides (Commissioner)

• Date	05 Feb 2020	Location	Brussels
  Subject	Discussion on Cancer and Europe's Beating Cancer Plan
  Cabinet	Cabinet of Commissioner Stella Kyriakides
  Portfolio	Health
  Attending	Stella Kyriakides (Commissioner) Tove Ernst (Cabinet member)
  Other Lobbyists	Eli Lilly and Company

• Date	27 Nov 2018	Location	Brussels
  Subject	Access to health services, including pharmaceuticals, in developing countries
  Cabinet	Cabinet of Vice-President Neven Mimica
  Portfolio	International Cooperation & Development
  Attending	Nils Behrndt (Cabinet member)

• Date	27 Nov 2018	Location	Brussels
  Subject	Health research in Horizon Europe
  Cabinet	Cabinet of Commissioner Carlos Moedas
  Portfolio	Research, Science and Innovation
  Attending	Giulia Del Brenna (Cabinet member)

• Date	21 Feb 2018	Location	Brussels
  Subject	HTA; Supplementary Protection Certificates (SPC)
  Cabinet	Cabinet of Commissioner Vytenis Andriukaitis
  Portfolio	Health & Food Safety
  Attending	Annika Nowak (Cabinet member)
  Other Lobbyists	SANOFI

• Date	15 Feb 2018	Location	Brussels
  Subject	pharmaceutical IP incentives
  Cabinet	Cabinet of Commissioner Elżbieta Bieńkowska
  Portfolio	Internal Market, Industry, Entrepreneurship and SMEs
  Attending	Fabrice Comptour (Cabinet member) Kaius Kristian Hedberg (Cabinet member)
  Other Lobbyists	Läkemedelsindustriföreningen

• Date	01 Feb 2018	Location	Brussels
  Subject	Patent Issues
  Cabinet	Cabinet of Vice-President Miguel Arias Cañete
  Portfolio	Climate Action & Energy
  Attending	Pierre Schellekens (Cabinet member)

• Date	25 Jan 2018	Location	Brussels
  Subject	European patent protection
  Cabinet	Cabinet of Commissioner Pierre Moscovici
  Portfolio	Economic and Financial Affairs, Taxation and Customs
  Attending	Lucie Mattera (Cabinet member)
  Other Lobbyists	SANOFI

• Date	25 Jan 2018	Location	Brussels
  Subject	Business discussion
  Cabinet	Cabinet of Commissioner Phil Hogan
  Portfolio	Agriculture & Rural Development
  Attending	Tom Tynan (Cabinet member)

• Date	25 Jan 2018	Location	Davos
  Subject	health policy
  Cabinet	Cabinet of Vice-President Günther Oettinger
  Portfolio	Budget & Human Resources
  Attending	Günther Oettinger (Commissioner)

• Date	21 Nov 2017	Location	Brussels
  Subject	Internal Market's industrial property legal framework relating to supplementary protection certificates (SPC) and patent research exemptions; innovation in the pharmaceutical industry
  Cabinet	Cabinet of Vice-President Jyrki Katainen
  Portfolio	Jobs, Growth, Investment and Competitiveness
  Attending	Jyrki Katainen (Vice-President)
  Other Lobbyists	Pfizer Inc.

• Date	21 Nov 2017	Location	Brussels
  Subject	research budget
  Cabinet	Cabinet of Vice-President Günther Oettinger
  Portfolio	Budget & Human Resources
  Attending	Günther Oettinger (Commissioner)

• Date	08 Nov 2017	Location	Brussels
  Subject	Economy and Investment in the EU Neighbourhood
  Cabinet	Cabinet of Vice-President Johannes Hahn
  Portfolio	European Neighbourhood Policy & Enlargement Negotiations
  Attending	Michael Karnitschnig (Cabinet member)

• Date	08 Nov 2017	Location	Brussels
  Subject	E Health
  Cabinet	Cabinet of Commissioner Mariya Gabriel
  Portfolio	Digital Economy and Society
  Attending	Manuel Mateo-Goyet (Cabinet member)

• Date	07 Nov 2017	Location	Brussels
  Subject	Innovation and patents in trade policy
  Cabinet	Cabinet of Vice-President Cecilia Malmström
  Portfolio	Trade
  Attending	Miguel Ceballos Baron (Cabinet member)

• Date	18 Jan 2017	Location	Davos
  Subject	Data, e-health
  Cabinet	Cabinet of Vice-President Andrus Ansip
  Portfolio	Digital Single Market
  Attending	Andrus Ansip (Vice-President) Aare Järvan (Cabinet member)

• Date	14 Jan 2016	Location	Brussels
  Subject	AECA Round-Table on “Dealing with Regulatory Burden
  Cabinet	Cabinet of First Vice-President Frans Timmermans
  Portfolio	Better Regulation, Interinstitutional Relations, the Rule of Law and the Charter of Fundamental Rights
  Attending	Bernardus Smulders (Cabinet member)
  Other Lobbyists	ArcelorMittal

• Date	03 Jun 2015	Location	Brussels
  Subject	New College and Better Regulation
  DG	Communications Networks, Content and Technology
  Attending	Robert Madelin (Director-General)
  Other Lobbyists	Association des Constructeurs Européens d'Automobiles

• Date	13 Mar 2015	Location	Brussels
  Subject	Industrial Policy for pharmaceuticals
  DG	Internal Market, Industry, Entrepreneurship and SMEs
  Attending	Daniel Calleja Crespo (Director-General)

• Date	12 Feb 2015	Location	Brussels
  Subject	Digital Single Market, Innovation
  DG	Communications Networks, Content and Technology
  Attending	Robert Madelin (Director-General)
  Other Lobbyists	EuropaBio

• Date	23 Jan 2015	Location	Davos
  Subject	Bilateral meeting the CEO of Novartis & EFPIA President
  Cabinet	Cabinet of Commissioner Carlos Moedas
  Portfolio	Research, Science and Innovation
  Attending	Carlos Moedas (Commissioner)

• Date	16 Jan 2015	Location	PRAGUE, CZECH REPUBLIC
  Subject	Round Table on Gender Diversity
  Cabinet	Cabinet of Commissioner Věra Jourová
  Portfolio	Justice, Consumers and Gender Equality
  Attending	Věra Jourová (Commissioner)
  Other Lobbyists	Accenture PLC